Form 4: Galecto, Inc. Director Amy B. Wechsler Reports Stock Option Grant

Director Amy B. Wechsler reports the acquisition of stock options in Galecto, Inc. related to her role on the Board of Directors.

Summary

• Amy B. Wechsler, a director of Galecto, Inc., filed a Form 4 on October 15, 2024, reporting changes in beneficial ownership.
• On October 11, 2024, Wechsler acquired stock options to purchase 720 shares and 480 shares of Galecto, Inc. common stock at an exercise price of $6.92.
• The first option for 720 shares vests in 36 equal monthly installments over three years from the award date.
• The second option for 480 shares represents a pro-rated annual grant to a non-employee director and vests in twelve equal monthly installments from the award date.
• Both options are subject to continued service through the applicable vesting date and expire on October 11, 2034.

Sentiment

Score: 7

Explanation: The document reflects a routine equity grant to a director, indicating standard corporate governance practices. It's a neutral to slightly positive signal as it aligns director interests with shareholders.

Positives

• The stock option grants align the director's interests with those of the shareholders.
• The vesting schedules incentivize continued service and contribution to the company.

Industry Context

Stock option grants are a common form of compensation for directors, aligning their interests with the long-term success of the company.

Comparison to Industry Standards

• Stock option grants to non-employee directors are a standard practice in publicly traded companies, including those in the biotechnology sector like Galecto, Inc.
• The vesting schedules (3 years and 1 year) are typical for director equity grants, similar to companies like Madrigal Pharmaceuticals and Viking Therapeutics.

Stakeholder Impact

• The stock option grants incentivize the director to contribute to the long-term success of the company, benefiting shareholders.
• The grants have a dilutive effect on existing shareholders, although the impact is likely minimal.

Key Dates

Keywords

Form 4, stock options, beneficial ownership, director, Galecto, Inc., GLTO, Wechsler